Posted by Michael Wonder on 07 Apr 2022
ICER publishes white paper evaluating reforms to orphan drug development, pricing and coverage
7 April 2022 - The white paper presents an analysis of the potential risks and benefits of reforms seeking to strengthen evidence on orphan drugs and to ensure that adequate incentives for orphan drug development are coupled to a more sustainable long-term trajectory for orphan drug pricing.
Boston, April 7, 2022 – The ICER published a new white paper in collaboration with researchers at NORC at the University of Chicago: “The Next Generation of Rare Disease Drug Policy: Ensuring Both Innovation and Affordability.
